Shilpa CDMO Invests $50 Million to Expand Peptide Manufacturing Capacity in India
Why the pharmaceutical CDMO India segment is racing into peptides: Shilpa’s $50 million plan, what is set for December 2026 and what is undisclosed.
Tag: cGMP manufacturing
Read More